Commitment By: BD and Direct Relief International
Location: Across the U.S.
Throughout the United States, nearly 20 million people are medically underserved and receive health care at one of more than 2,300 non-profit clinics and health centers. These providers operate with limited resources, but use creative and innovative techniques to provide high quality primary care and referral services to the nation’s most vulnerable people. The patient population has been growing in recent years, and will likely continue to do so as an increasing number of providers in some parts of the country decline to accept Medicaid insurance. Serving this low-income and uninsured or under-insured population requires a dynamic strategy that improves access to care, reduce health disparities, and increase awareness and information about healthy practices.
BD (Becton, Dickinson and Company) is a global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The company is dedicated to improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. Direct Relief is an organization that provides humanitarian medical aid to those who need it by supporting over 1,000 CCHCs throughout the country. These clinics provide primary care, dental services, behavioral health, and support services to children, adults, and families regardless of their ability to pay.
BD, in collaboration with Direct Relief, is launching a multi-year initiative to identify and provide awards to clinics and health centers with innovative models of care, and to address local resource constraints through an expanded syringe donation program. In 2013, BD and Direct Relief will grant two Helping Build Healthy Communities (HBHC) awards $100,000 to initiatives that have demonstrated proven success in improving care for people with diabetes or cervical cancer. The commitment made by BD and Direct Relief is one of 31 Pledges to Action made at the 2013 Health Matters conference. In total, these pledges are worth more than $100 million and will benefit more than 25 million people.
- Over the next four years, BD will donate $2 million to support the work of nonprofit clinics and health centers. They will also contribute 20 million insulin syringes, which Direct Relief will distribute to providers throughout the country, helping to ease the financial barriers to uninsured patients just starting on insulin.
- Financial awards provided to innovative CCHCs will allow these facilities to expand services that are working well for their most vulnerable patients, and bring attention to effective and innovative practices that could benefit other facilities and communities.
Learn more about becoming a Clinton Health Matters Initiative commitment-maker.